LBBW Aktienanleihe OMV 28.04.2025/ DE000LB46CN2 /
9/26/2024 3:15:12 PM | Chg.-0.280 | Bid4:20:45 PM | Ask4:20:45 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
97.150EUR | -0.29% | 97.180 Bid Size: 250,000 |
97.380 Ask Size: 250,000 |
OMV AG | 35.16 EUR | 4/28/2025 | Call |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center